UiPath, Inc. (NYSE:PATH) is one of the cheap AI stocks to buy in 2026. On February 23, 2026, UiPath announced a suite of agentic AI solutions for healthcare providers and payers, targeting ...
UiPath (NYSE:PATH) executives used the company’s latest earnings call question-and-answer session to emphasize what they ...
AI company UiPath was on a trajectory of double-digit, year-over-year revenue growth that suddenly stopped after Q1. The company lowered its fiscal 2025 revenue guidance, and its CEO resigned. Despite ...
At UiPath’s Fusion London event, NFU Mutual’s automation lead explains how the UK insurer built a working agentic claims process, found overpayments humans missed, and built a credible business case.
UiPath embeds Anthropic’s Claude LLMs to fuel UiPath Autopilot for everyone, Clipboard AI, and a new GenAI healthcare solution to offer customers improved productivity, cost savings, and ...
UiPath PATH is pushing deeper into agentic automation, aiming to move beyond task-level robotic process automation into systems that can reason, plan, and execute across workflows. The strategy is ...
UiPath Inc. today announced that it has acquired Cloud Elements Inc., a venture-backed startup with a software platform used by companies to integrate their business applications with one another.
UiPath, Inc. (NYSE: PATH), a global leader in agentic automation, today announced financial results for its fourth quarter and full year fiscal 2026 ended January 31, 2026.
UiPath's share price has risen in recent months despite ongoing losses and slow growth. While market conditions are stable, there is still elevated deal scrutiny and longer sales cycles, particularly ...
UiPath's strategic focus on long-term enterprise automation is driving positive outcomes, evident from record deals and strengthened partnerships. The integration of generative AI technologies and the ...
RPA is a hot tech theme right now, as many organizations are looking for ways to automate redundant work. UiPath's software-based bots are enjoying a brisk uptick in demand, but they aren't alone in ...